Persistently elevated C-reactive protein level in the first year of antiretroviral therapy, despite virologic suppression, is associated with HIV disease progression in resource-constrained settings

Journal of Infectious Diseases

Volumn 213, Issue 7, 2016, Pages 1074-1078

  Shivakoti, Rupak ^a   Yang, Wei Teng ^a   Berendes, Sima ^a,n   Mwelase, Noluthando ^d   Kanyama, Cecilia ^c   Pillay, Sandy ^e   Samaneka, Wadzanai ^f   Santos, Breno ^g   Poongulali, Selvamuthu ⁱ   Tripathy, Srikanth ^j   Riviere, Cynthia ^k   Lama, Javier R ^l   Cardoso, Sandra W ^h   Sugandhavesa, Patcharaphan ^m   Balagopal, Ashwin ^a   Gupte, Nikhil ^a   Semba, Richard D ^a   Campbell, Thomas B ^b   Bollinger, Robert C ^a   Gupta, Amita ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MALAWI   (Malawi)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e DURBAN UNIVERSITY OF TECHNOLOGY   (South Africa)

^f UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^g Neonatal Unit   (Brazil)

^h Funda??o Oswaldo Cruz   (Brazil)

ⁱ YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^j NATIONAL AIDS RESEARCH INSTITUTE   (India)

^k Centers Institute of Infectious Diseases and Reproductive Health   (Haïti)

^l ASOCIACIÓN CIVIL IMPACTA SALUD Y EDUCACIÓN   (Peru)

^m Research Institute for Health Sciences   (Thailand)

ⁿ LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

Antiretroviral therapy; CRP; HIV; Inflammation; Persistent inflammation

Indexed keywords

ANTIRETROVIRUS AGENT; C REACTIVE PROTEIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; C REACTIVE PROTEIN BLOOD LEVEL; CASE STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); VIRUS INHIBITION; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; HEALTH; HIV INFECTIONS; INFLAMMATION; METABOLISM; MULTICENTER STUDY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

ADULT; ANTI-HIV AGENTS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; GLOBAL HEALTH; HIV INFECTIONS; HUMANS; INFLAMMATION; MALE; TREATMENT FAILURE;

EID: 84962609078     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv573     Document Type: Article

References (15)

1. Lau B, Sharrett AR, Kingsley LA, et al. C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch Intern Med 2006; 166:64-70.
2. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5:e203.
3. Ledwaba L, Tavel JA, Khabo P, et al. Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease. PloS One 2012; 7:e24243.
4. Yoon C, Davis JL, Huang L, et al. Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV. J Acquir Immune Defic Syndr 2014; 65:551-6.
5. McDonald B, Moyo S, Gabaitiri L, et al. Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial. AIDS Res Hum Retroviruses 2013; 29:993-9.
6. Campbell TB, Smeaton LM, Kumarasamy N, et al. Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings. PLoS Med 2012; 9:e1001290.
7. Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J Clin Epidemiol 1999; 52:1165-72.
8. Sage EK, Noursadeghi M, Evans HE, et al. Prognostic value of C-reactive protein in HIV-infected patients with Pneumocystis jirovecii pneumonia. Int J STD AIDS 2010; 21:288-92.
9. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr 2009; 12:444-54.
10. Sudfeld CR, Isanaka S, Aboud S, et al. Association of serum albumin concentration with mortality, morbidity, CD4 T-cell reconstitution among Tanzanians initiating antiretroviral therapy. J Infect Dis 2013; 207:1370-8.
11. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340:448-54.
12. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111:1805-12.
13. Drain PK, Kupka R, Msamanga GI, Urassa W, Mugusi F, Fawzi WW. C-reactive protein independently predicts HIV-related outcomes among women and children in a resource-poor setting. AIDS 2007; 21:2067-75.
14. Rimaniol AC, Zylberberg H, Zavala F, Viard JP. Inflammatory cytokines and inhibitors in HIV infection: correlation between interleukin-1 receptor antagonist and weight loss. AIDS 1996; 10:1349-56.
15. Ford ES, Liu S, Mannino DM, Giles WH, Smith SJ. C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults. Eur J Clin Nutr 2003; 57:1157-63.